Ozempic maker Novo Nordisk's board slims down as directors quit
Source: BBC
The company behind weight-loss jab Wegovy and diabetes drug Ozempic will have a boardroom clear-out, with seven board members including the chairman set to depart.Novo Nordisk on Tuesday said chairman Helge Lund, vice chair Henrik Poulsen and five directors will not stand for re-election at an extraordinary investor meeting in November.It's the latest in a raft of changes at the Danish company, which welcomed a…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at BBC